SO
TNXP icon

STRS Ohio’s Tonix Pharmaceuticals TNXP Stock Holding History

STRS Ohio’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,800
Closed -$122K – 2219
2025
Q4 		$122K Buy
7,800
+700
+10% +$12.9K ﹤0.01% 1752
2025
Q3 		$172K Buy
7,100
+4,300
+154% +$160K ﹤0.01% 1610
2025
Q2 		$101K Buy
+2,800
New +$73.4K ﹤0.01% 1857
2022
Q2 		– Hold
0
– -$17K – 2287
2022
Q1 		– Hold
0
– – – 2062
2021
Q4 		– Hold
0
– – – 2084
2021
Q3 		– Hold
0
– – – 2087
2021
Q2 		– Hold
0
– – – 2013

Other funds holding TNXP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JHC
Jones Hill Capital New York $466M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

STRS Ohio's TNXP Position: Q1 2026 in Review

STRS Ohio sold out of Tonix Pharmaceuticals (TNXP) in Q1 2026, closing a stake of 7,800 shares — an estimated $122K sold.

STRS Ohio first reported a position in TNXP in Q2 2025 and held it in 3 quarters. The position peaked at $172K in Q3 2025. 81 funds tracked by Wall St. Rank hold TNXP as of Q1 2026.

  • STRS Ohio reported no remaining Tonix Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • STRS Ohio sold 7,800 Tonix Pharmaceuticals shares in Q1 2026, an estimated $122K.
  • STRS Ohio first reported a position in Tonix Pharmaceuticals in Q2 2025 and held it in 3 quarters.
  • STRS Ohio's Tonix Pharmaceuticals position peaked at $172K in Q3 2025.
  • 81 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.